About BioBank
BioBank is a Healthcare company based in Presles-en-brie (France) founded in 1999, and was acquired by Turenne Groupe in September 2014. Preserves develops orthopedic and dental grafts. Its focus areas include Life Sciences, Orthopedics, Medical Devices and Therapies.
Company details
BioBank was founded in 1999 and operates in the tissue banking sector, focusing on allografts sourced from human femoral heads obtained during hip arthroplasty from living donors. Products for orthopedic surgery include whole and half femoral heads, cancellous bone blocks, wedges, and granules in flasks or syringes. Dental surgery items are provided in powdered form. Preservation occurs in a tissue bank authorized by Frances ANSM agency.
- Headquarters Presles-en-brie, France
- Stage Acquired
- SectorsHealthcare
- Emailβ’β’β’β’β’β’β’β’
- Website biobank.fr
- Social LinkedIn
- Acquired by Turenne Groupe (Sep 2014)
- InvestorsAltur Investissement
& 3 more
- Acquired byTurenne Groupe
(Sep 2014)
Funding Insights of BioBank
- Total Rounds 2
- Investors Count 2
All 2 funding rounds of BioBank with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec 2018 | Unspecified | β | β | ||
| Jul 2018 | Private Equity Round | β | Altur Investissement | β |
4 investors in total: 4 institutional.
Investors in BioBank
BioBank has secured backing from 4 investors, including venture fund investors. Prominent investors backing the company include Altur Investissement, Verto and Fa Diese.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Growth equity investments are made in B2B Software and Healthtech. | vertogrowth.com | Paris, France | ||
Investments are directed toward high-potential companies across multiple industries. | 1999 | altur-investissement.com | Paris, France | |
| fadiese.fr | ||||
Private equity investments are made in companies across diverse sectors. | turennecapital.com | Paris, France |
Investor details for BioBank
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of BioBank
4 dated milestones of BioBank across 19 years, from founding to its latest funding, stage changes and deals.
- Founded BioBank is founded.
- Exit Acquired by Turenne Groupe.
- Funding First funding round.
- Funding Latest funding round, Unspecified,.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Biobank
Complete news archive for BioBank
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about BioBank
BioBank was founded in 1999 and raised its 1st funding round 19 years after it was founded.
BioBank is headquartered in Presles-en-brie, France. It is registered at Presles-en-brie, Seine-et-marne, France.
BioBank was founded in 1999 and operates in the tissue banking sector, focusing on allografts sourced from human femoral heads obtained during hip arthroplasty from living donors. Products for orthopedic surgery include whole and half femoral heads, cancellous bone blocks, wedges, and granules in flasks or syringes. Dental surgery items are provided in powdered form. Preservation occurs in a tissue bank authorized by Frances ANSM agency.
BioBank has 4 investors. Key investors include Altur Investissement, Verto, Fa Diese, and Turenne Groupe.
Yes. BioBank was acquired by Turenne Groupe in September 2014.

